Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Gland Pharma Ltd.
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)42.4046.9047.4473.8163.07
Diluted EPS (Rs.)42.4046.9047.4373.8162.99
Cash EPS (Rs.)65.3367.8256.3380.4666.98
Book Value[Excl.RevalReserv]/Share (Rs.)555.40529.65483.23435.64360.86
Book Value[Incl.RevalReserv]/Share (Rs.)555.40529.65483.23435.64360.86
Revenue From Operations / Share (Rs.)340.89343.92220.07267.85211.68
PBDIT / Share (Rs.)89.9891.2776.82105.5487.84
PBIT / Share (Rs.)67.0570.3567.9198.8381.80
PBT / Share (Rs.)64.5068.7664.0398.5181.59
Net Profit / Share (Rs.)42.4046.9047.4273.7560.94
NP After MI And SOA / Share (Rs.)42.4046.9047.4273.7560.94
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)26.3926.5334.9039.4041.49
PBIT Margin (%)19.6620.4530.8536.8938.64
PBT Margin (%)18.9219.9929.0936.7738.54
Net Profit Margin (%)12.4313.6321.5427.5328.79
NP After MI And SOA Margin (%)12.4313.6321.5427.5328.79
Return on Networth / Equity (%)7.638.859.8116.9216.88
Return on Capital Employeed (%)11.4312.5013.8922.3922.36
Return On Assets (%)6.227.248.8915.4615.34
Long Term Debt / Equity (X)0.010.010.000.000.00
Total Debt / Equity (X)0.020.030.000.000.00
Asset Turnover Ratio (%)0.510.580.430.610.65
      
LIQUIDITY RATIOS     
      
Current Ratio (X)4.334.049.4610.0510.00
Quick Ratio (X)3.262.856.808.027.51
Inventory Turnover Ratio (X)1.181.251.101.661.72
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)35.3057.38169.90330.81421.28
Interest Coverage Ratio (Post Tax) (%)17.6330.48113.46232.15293.28
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)23946.0928818.2817126.9950622.6337532.51
EV / Net Operating Revenue (X)4.265.094.7311.5010.84
EV / EBITDA (X)16.1519.1713.5429.1926.12
MarketCap / Net Operating Revenue (X)4.675.365.7612.2111.71
Price / BV (X)2.873.482.637.506.87
Price / Net Operating Revenue (X)4.675.365.7612.2111.71
EarningsYield0.020.020.030.020.02
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)42.40
Diluted EPS (Rs.)42.40
Cash EPS (Rs.)65.33
Book Value[Excl.RevalReserv]/Share (Rs.)555.40
Book Value[Incl.RevalReserv]/Share (Rs.)555.40
Revenue From Operations / Share (Rs.)340.89
PBDIT / Share (Rs.)89.98
PBIT / Share (Rs.)67.05
PBT / Share (Rs.)64.50
Net Profit / Share (Rs.)42.40
NP After MI And SOA / Share (Rs.)42.40
PROFITABILITY RATIOS 
PBDIT Margin (%)26.39
PBIT Margin (%)19.66
PBT Margin (%)18.92
Net Profit Margin (%)12.43
NP After MI And SOA Margin (%)12.43
Return on Networth / Equity (%)7.63
Return on Capital Employeed (%)11.43
Return On Assets (%)6.22
Long Term Debt / Equity (X)0.01
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)0.51
LIQUIDITY RATIOS 
Current Ratio (X)4.33
Quick Ratio (X)3.26
Inventory Turnover Ratio (X)1.18
COVERAGE RATIOS 
Interest Coverage Ratio (%)35.30
Interest Coverage Ratio (Post Tax) (%)17.63
VALUATION RATIOS 
Enterprise Value (Cr.)23946.09
EV / Net Operating Revenue (X)4.26
EV / EBITDA (X)16.15
MarketCap / Net Operating Revenue (X)4.67
Price / BV (X)2.87
Price / Net Operating Revenue (X)4.67
EarningsYield0.02